{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:33:36Z","timestamp":1791977616297,"version":"4.4.0"},"reference-count":45,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"vor","delay-in-days":9330,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[1981,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine the auditory toxicity effects of long\u2010term cis\u2010dichlorodiammineplatinum II therapy, pure tone hearing thresholds were measured prior to therapy and repeated before each subsequent treatment. CDDP was given by a slow intravenous drip method at a low dose of 1 mg\/kg body weight, with 37.5 gm mannitol, once a week for six treatments and every 3 weeks thereafter. From a group of 173 genitourinary cancer patients treated, 50 male patients were selected who received at least 12 months of CDDP with no active conductive ear pathology, and whose audiograms obtained at baseline, 6th weeks, 26th weeks, and 52nd weeks of treatment were all available for comparison. Pure tone threshold levels deteriorated across time particularly by the 52nd week and at the higher frequencies. Threshold differences across time were statistically significant and within a linear trend. Of the 50 cases, 30% showed suspect or no ototoxicity, 26% mild, 32% moderate, 2% marked, and 4% showed severe ototoxic changes. Of the two cases who developed severe ototoxicity, one showed complete recovery. There was partial recovery in 26% and no recovery in 54%. Individual variability in susceptibility to and recovery from ototoxicity necessitates systematic audiometric monitoring throughout the therapy.<\/jats:p>","DOI":"10.1002\/jso.2930160203","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T06:56:29Z","timestamp":1171954589000},"page":"111-123","source":"Crossref","is-referenced-by-count":81,"title":["Auditory toxicity effects of long\u2010term cis\u2010dichlorodiammineplatinum II therapy in genitourinary cancer patients"],"prefix":"10.1002","volume":"16","author":[{"given":"Nila V.","family":"Aguilar\u2010Markulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summolu","family":"Beckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Priore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Mettlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/222385a0"},{"key":"e_1_2_1_3_2","first-page":"950","article-title":"Antitumor and antimitogenic properties of cis\u2013dichloro(dipyridine)platinum(II)","volume":"31","author":"Gale G","year":"1971","journal-title":"Cancer Res"},{"key":"e_1_2_1_4_2","first-page":"2","article-title":"Effects of cis\u2013platinum diamminodichloride II on growth of 7, 12\u2013dimethylbenzanthracene (DMBA) induced mammary tumors in female rats","volume":"12","author":"Welsch C","year":"1970","journal-title":"Pharmacologist"},{"key":"e_1_2_1_5_2","first-page":"255","volume-title":"Advances in Antimicrobial and Antineoplastic Chemotherapy","author":"Hill JM","year":"1972"},{"key":"e_1_2_1_6_2","first-page":"459","article-title":"Cis\u2013diamminedichloroplatinum (NSC\u2013119875): A phase I study","volume":"57","author":"Higby D","year":"1973","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_7_2","first-page":"465","article-title":"Clinical evaluation of toxic effects of cis\u2013diamminedi\u2013chloroplatinum (NSC\u2013119875) phase I clinical study","volume":"57","author":"Talley RW","year":"1973","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197212)30:6<1451::AID-CNCR2820300606>3.0.CO;2-Q"},{"key":"e_1_2_1_9_2","first-page":"191","article-title":"Clinical trials of cis\u2013diamminedichloroplatinum (NSC\u2013119875)","volume":"57","author":"Lippman AJ","year":"1973","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_10_2","first-page":"621","article-title":"Review of the current clinical status of platinum coordination complexes in cancer chemotherapy","volume":"59","author":"Gottlieb JA","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_11_2","first-page":"178","article-title":"Cis\u2013platinum (II) diamminedichloride","volume":"48","author":"Wiltshaw E","year":"1974","journal-title":"Cancer Res"},{"key":"e_1_2_1_12_2","first-page":"995","article-title":"Phase II study of cis\u2013dichlorodiammineplatinum (II) (NSC\u2013119875) in combination with cyclophosphamide (NSC\u201326271) in the treatment of human malignancies","volume":"59","author":"Piel IJ","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_13_2","article-title":"Phase I clinical trial of combined therapy with 5Fu (NSC\u201319893) and cis\u2013platinum (II) diamminedichloride (NSC\u2013119875)","volume":"34","author":"Ellerby R","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)57047-0"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0022-5347(17)57527-8","article-title":"Treatment of advanced bladder cancer with cis\u2013diamminedichloroplatinum: A pilot study","volume":"119","author":"Merrin CE","year":"1978","journal-title":"J Urol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)57535-7"},{"key":"e_1_2_1_17_2","unstructured":"MerrinCE: Treatment of genito\u2013urinary tumors with cis\u2013diamminedichloroplatinum: Experience in 250 patients.Cancer Treat Rep1979."},{"key":"e_1_2_1_18_2","first-page":"1539","article-title":"Cis\u2013dichlorodiammineplatinum (II) for the treatment of advanced ovarian cancer","volume":"63","author":"Young RC","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_19_2","first-page":"23","article-title":"High\u2013dose cis\u2013diamminedichloroplatinum therapy in patients with advanced breast cancer: Pharmacokinetics, toxicity, and therapeutic efficacy","volume":"3","author":"Ostrow S","year":"1980","journal-title":"Cancer Clin Trials"},{"key":"e_1_2_1_20_2","first-page":"780","article-title":"Cis\u2013platinum chemotherapy in head and neck cancers","volume":"86","author":"Jacobs C","year":"1978","journal-title":"Otorhinolaryngology"},{"key":"e_1_2_1_21_2","first-page":"1527","article-title":"Toxic effects of cis\u2013dichlorodiammineplatinum (II)in man","volume":"63","author":"Von Hoff DD","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO;2-N"},{"key":"e_1_2_1_23_2","first-page":"116","article-title":"The long\u2013term effect of cis\u2013platinum diamminedichloride (CPDD) in renal function in man","volume":"18","author":"Dentino ME","year":"1977","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_1_24_2","first-page":"9","article-title":"Nephrotoxicity of cis\u2013dichlorodiammineplatinum (II)","volume":"63","author":"Krakoff IH","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_25_2","first-page":"871","article-title":"Effects of cis\u2013diamminedichloroplatinum (NSC\u2013119875) on hearing function in man","volume":"58","author":"Piel IJ","year":"1974","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563657808988252"},{"key":"e_1_2_1_27_2","first-page":"243","article-title":"A new method to prevent toxicity with high doses of cis\u2013diammineplatinum (therapeutic efficacy in previously treated widespread and recurrent testicular tumors)","volume":"17","author":"Merrin CE","year":"1976","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J"},{"key":"e_1_2_1_29_2","first-page":"467","article-title":"Cis\u2013dichlorodiammineplatinum (II) (NSC\u2013119875): Hearing loss and other toxic effects in rhesus monkeys","volume":"59","author":"Stadnicki S","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-008X(73)80009-2"},{"key":"e_1_2_1_31_2","unstructured":"HeymanI ThompsonG SchaeppiU et al: Platinum diammine dichlorocis\u2013NSC\u2013119875 Preclinical pharmacological evaluation of IV injection in dogs monkeys and mice. US Department of Commerce National Technical Information Service 1971 PB\u2013119719 162pp."},{"key":"e_1_2_1_31_3","first-page":"1083272","volume":"17","year":"1971","journal-title":"Abstracted in Chem Abstr"},{"key":"e_1_2_1_32_2","first-page":"323","volume-title":"Biochemical Mechanisms in Hearing and Deafness. Research Otology International Symposium","author":"Hawkins JE","year":"1970"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1971.00770060901010"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/00221309.1955.9918348"},{"key":"e_1_2_1_34_3","first-page":"96","volume-title":"Hearing Measurement: A Book of Readings","author":"Ventry IM","year":"1971"},{"key":"e_1_2_1_35_2","unstructured":"BrooksDN:Evaluation of \u201chard to test\u201d children and adults. In Singh S Lynch J (eds): Diagnostic Procedures in Hearing Speech and Language 1978."},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)31697-2"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1963.00750010399008"},{"key":"e_1_2_1_38_2","first-page":"349","article-title":"An audiometric approach to noise control","volume":"24","author":"Hermann ER","year":"1963","journal-title":"Am Industr Hyg Assoc J"},{"key":"e_1_2_1_39_2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0030-6665(20)32521-4","article-title":"Hearing loss due to noise exposure","volume":"11","author":"Heffler AJ","year":"1978","journal-title":"Otolaryngol Clin North Am"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0030-6665(20)32526-3","article-title":"Ototoxic agents","volume":"11","author":"Marlowe FI","year":"1978","journal-title":"Otolaryngol Clin North Am"},{"key":"e_1_2_1_41_2","first-page":"849","volume-title":"Scientific Foundations of Otolaryngology","author":"Ballantyne J","year":"1976"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016487309139733"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348947608500108"},{"key":"e_1_2_1_44_2","first-page":"5","volume-title":"Handbook of Auditory and Vestibular Research Methods","author":"Hawkins JE","year":"1976"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.2930160203","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.2930160203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T21:36:13Z","timestamp":1699824973000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.2930160203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1981,1]]}},"alternative-id":["10.1002\/jso.2930160203"],"URL":"https:\/\/doi.org\/10.1002\/jso.2930160203","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,1]]}}}